Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| UTI - Healthcare Fund | Axis ESG Integration Strategy Fund | |
|---|---|---|
| Category | Sectoral / Thematic | Sectoral / Thematic |
| Plan | Regular | Regular |
| Fund house | UTI | Axis |
| NAV | ₹351.8699 | ₹21.0800 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | 20.6 years | 6.8 years |
| Expense ratio | 2.2% | 2.6% |
| Stars | ★★★★★ | ★★★★★ |
| Growth Score | 84.80 | 28.20 |
Returns
| UTI - Healthcare Fund | Axis ESG Integration Strategy Fund | |
|---|---|---|
| 1 month | +11.29% | +6.63% |
| 3 months | +3.49% | −0.38% |
| 6 months | +13.42% | +3.89% |
| YTD | +23.91% | −3.88% |
| 1 year | +21.60% | −3.92% |
| 3 years (CAGR) | +22.05% | +7.49% |
| 5 years (CAGR) | +16.72% | +4.29% |
| 10 years (CAGR) | +14.81% | — |
| Since launch | +13.83% | +11.50% |
Risk
| UTI - Healthcare Fund | Axis ESG Integration Strategy Fund | |
|---|---|---|
| Volatility | 15.3% | 14.0% |
| Downside volatility | 9.0% | 10.4% |
| Sharpe | 1.01 | 0.07 |
| Sortino | 1.73 | 0.10 |
| Calmar | 1.38 | 0.40 |
| Return / risk | 1.44 | 0.53 |
| Deepest fall | −33.91% | −25.09% |
| Days to recover | 206 | 531 |
| Below its high | +0.00% | −9.45% |
Against benchmark
| UTI - Healthcare Fund | Axis ESG Integration Strategy Fund | |
|---|---|---|
| Alpha | +2.15% | — |
| Beta | 0.91 | — |
| R² | 85.2% | — |
| Up capture | 90.6% | — |
| Down capture | 74.3% | — |
| Tracking error | 6.1% | — |
| Information ratio | 0.15 | — |
| Treynor | 0.16 | — |
Consistency
| UTI - Healthcare Fund | Axis ESG Integration Strategy Fund | |
|---|---|---|
| Best 1-year | +99.77% | +67.94% |
| Middle 1-year | +12.27% | +8.07% |
| Worst 1-year | −26.83% | −17.67% |
| 1-year periods with a loss | 30.8% | 31.3% |
| Middle 3-year | +17.73% | +11.69% |
| Positive months | 66.7% | 63.9% |
| Best day | +3.11% | +3.73% |
| Worst day | −3.39% | −3.59% |
| Worst 5% day | −1.44% | −1.23% |
| Positive days | 56.6% | 51.4% |
| NAVs a year | 247 | 251 |
SIP of ₹10,000 a month
| UTI - Healthcare Fund | Axis ESG Integration Strategy Fund | |
|---|---|---|
| 5-year XIRR | +21.04% | +6.26% |
| 5-year value | ₹10,22,637 | ₹7,05,168 |
| 3-year XIRR | +18.71% | +2.23% |
| 1-year XIRR | +29.75% | +1.90% |
Holdings overlap i
| UTI - Healthcare Fund | Axis ESG Integration Strategy Fund | |
|---|---|---|
| UTI - Healthcare Fund | — | 10% |
| Axis ESG Integration Strategy Fund | 10% | — |
Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.
Held by all of them
| Stock | UTI - Healthcare Fund | Axis ESG Integration Strategy Fund |
|---|---|---|
| Sun Pharmaceutical Industries Limited | 7.44% | 2.77% |
| Anthem Biosciences Limited | 1.74% | 1.67% |
| Biocon Limited | 1.53% | 2.29% |
| Metropolis Healthcare Limited | 1.47% | 1.74% |
| IPCA Laboratories Limited | 2.54% | 1.35% |
| Alkem Laboratories Limited | 3.66% | 0.73% |
| Gland Pharma Limited | 3.89% | 0.39% |
Sectors and company size
| UTI - Healthcare Fund | Axis ESG Integration Strategy Fund | |
|---|---|---|
| Large companies | 19.2% | 49.8% |
| Mid companies | 35.3% | 13.1% |
| Small companies | 38.9% | 21.2% |
| Top 10 holdings | 46.6% | 49.5% |
| Largest sector | Pharmaceuticals & Biotechnology 69% | Finance 13% |